Lakeshore Biopharma Co. Ltd.Preferred / convertible
13F holders, Q3 2024 (September 30)21holders −2
2new positions
4sold out
1famous investor
$0.09avg. 13F price*
At the end of Q3 2024, 21 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings, down 2 from Q2 2024. 2 opened new positions and 4 sold out. The largest holders were Athos Capital Ltd ($88K), Valliance Asset Management Ltd ($50K) and BFAM Partners (Cayman) Ltd ($44K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $11K |
| Exits | 4 | $104K |
All 13F filers, Q2 2024 → Q3 2024: 167,400 shares bought and 1,199,263 shares sold, net −1,031,863 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Athos Capital Ltd | — | No change | 128,981 | $88K |
| Valliance Asset Management Ltd | — | No change | 750,000 | $50K |
| BFAM Partners (Cayman) Ltd | — | No change | 550,000 | $44K |
| Jane Street Group, LLC | — | No change | 498,301 | $33K |
| Finepoint Capital LP | — | No change | 489,999 | $24K |
| Bracebridge Capital, LLC | — | No change | 232,323 | $15K |
| Cowen and Company, LLC | — | Reduce -8.3% | 212,849 | $14K |
| Ovata Capital Management Ltd | — | New | 150,000 | $10K |
| Q Global Advisors, LLC | — | No change | 130,600 | $9K |
| Whitebox Advisors LLC | — | No change | 125,000 | $8K |
| Calamos Advisors LLC | — | No change | 146,040 | $7K |
| Walleye Capital LLC | — | No change | 99,905 | $7K |
| Saba Capital Management, L.P. | — | No change | 97,299 | $6K |
| Cantor Fitzgerald, L. P. | — | No change | 76,931 | $5K |
| D. E. Shaw & Co. | — | No change | 100,000 | $5K |
| Clear Street LLC | — | Reduce -2.7% | 48,168 | $3K |
| Meteora Capital, LLC | — | No change | 25,000 | $2K |
| Two Sigma Securities, LLC | — | New | 17,400 | $1K |
| SkyView Investment Advisors, LLC | — | No change | 12,210 | $1K |
| Ancora Advisors LLC | — | No change | 5,050 | $334 |
| HGC Investment Management Inc. | — | No change | 5,000 | $331 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.